Leveraging on its key technological competences, polymers chemistry, cell biology and materials sciences, Volumina Medical has developed a technology platform applicable to different areas of reconstructive, plastic and aesthetic surgery, a fast-growing market (+11% annual growth since 2013, expected to be 12% in during the next five years).

The company is committed to become a leading and reliable actor in the field of regenerative technologies of soft tissues, providing safe cutting-edge technologies, limiting uncertainty and saving time both for patients and surgeons. The company strives to grow through its strategy: Understand, Execute, Optimize, Accelerate.

Volumina Medical’s mission is to develop its first product, an injectable scaffold, and to obtain the approval to penetrate the European Market first with an indication for intermediate volumes.